Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/1/2021
SIETES contiene 93213 citas

 
 
 1 a 20 de 34 siguiente >>
Presentar resultados
Seleccionar todas
2.Tiene citas relacionadas Cita con resumen
Rane A, Ekström L. Androgens and doping tests: genetic variation and pit-falls. Br J Clin Pharmacol 2012;74:3-15. [Ref.ID 93372]
3.Tiene citas relacionadas
Ritter JM. Sex, steroids and anabolic androgens in athletics. Br J Clin Pharmacol 2012;74:1-2. [Ref.ID 93371]
4.Tiene citas relacionadas Cita con resumen
Werner C, Fürster T, Widmann T, Pöss J, Roggia C, Hanhoun M, Scharhag J, Büchner N, Meyer T, Kindermann W, Haendeler J, Böhm M, Laufs U. Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall. Circulation 2009;120:2438-47. [Ref.ID 87648]
5.Tiene citas relacionadas Cita con resumen
Anónimo. Probiotics or con?. Lancet 2008;371:624. [Ref.ID 82234]
6.Tiene citas relacionadas Cita con resumen
Wright JM, Abramson J. Statins for primary prevention of coronary artery disease. Authors' reply. Lancet 2007;369:1079. [Ref.ID 79684]
7.Tiene citas relacionadas Cita con resumen
Mascitelli L, Pezzetta F. Statins for primary prevention of coronary artery disease. Lancet 2007;369:1078-9. [Ref.ID 79683]
8. Cita con resumen
Anónimo. L Carnitine. Med Lett Drugs Ther 2004;46:95-6. [Ref.ID 72315]
9. Cita con resumen
Anónimo. Performance-enhancing drugs. Med Lett Drugs Ther 2004;46:57-9. [Ref.ID 71022]
10.
Chester N, Mottram DR, Reilly T, Powell M. Elimination of ephedrines in urine following multiple dosing: the consequences for athletes, in relation to doping control. Br J Clin Pharmacol 2004;1:62-7. [Ref.ID 68801]
11.
Anónimo. Medical aspects of drug use in the gym. Drug Ther Bull 2004;42:1-5. [Ref.ID 68779]
12. Cita con resumen
Kondro W. Athletes' "designer steroid" leads to widening scandal. Lancet 2003;362:1466. [Ref.ID 67990]
13.
Kennedy M. Adverse drug reactions in athletes. Adv Drug React Bull 2003;221:847-50. [Ref.ID 67695]
14.
Noakes T. Oversconsumption of fluids by athletes. BMJ 2003;327:113-4. [Ref.ID 66925]
15.
Kujala UM, Sarna S, Karpio J. Use of medications and dietary supplements in later years among male former top-level athletes. Arch Intern Med 2003;163:1064-8. [Ref.ID 66277]
16. Cita con resumen
Jenkins P. Doping in sport. Lancet 2002;360:99-100. [Ref.ID 63124]
17.
Birchard K. Past, present, and future of drug abuse at the Olympics. Lancet 2000;356:1008. [Ref.ID 53906]
18.
Larkin M. New test added to armoury against performance-enhancing drugs. Lancet 2000;355:2053. [Ref.ID 51393]
19.
Ventura R, Segura J, Bergés R, Fitch KD, Morton AR, Berruezo S, Jiménez C. Distinction of inhaled and oral salbutamol by urine analysis using conventional screening procedures for doping control. Ther Drug Monit 2000;22:277-82. [Ref.ID 51258]
20. Cita con resumen
Cheng Y, Macera C, Davis DR, Ainsworth BE, Troped PJ, Blair SN. Physical activity and self-reported, physician-diagnosed osteoarthritis: is physical activity a risk factor?. J Clin Epidemiol 2000;53:315-22. [Ref.ID 49970]
Seleccionar todas
 
 1 a 20 de 34 siguiente >>